We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.45%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$30.8B
AUM Growth
+$741M
(+2.5%)
Cap. Flow
-$14.8B
Cap. Flow
% of AUM
-47.97%
Top 10 Holdings %
Top 10 Hldgs %
8.31%
Holding
851
New
152
Increased
227
Reduced
305
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$92.3M |
| 2 |
Clorox
CLX
|
+$90.2M |
| 3 |
Universal Health Services
UHS
|
+$86.5M |
| 4 |
American International
AIG
|
+$81.4M |
| 5 |
Corteva
CTVA
|
+$74.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$13.2B |
| 2 |
Bank of America
BAC
|
+$164M |
| 3 |
DuPont de Nemours
DD
|
+$120M |
| 4 |
Intuitive Surgical
ISRG
|
+$102M |
| 5 |
Johnson & Johnson
JNJ
|
+$93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 14.54% |
| 3 | Financials | 14.22% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Penumbra
PEN
$12.5B
| $93.8M | 0.3% |
585,938
+3,947
| +0.7% | +$570K |
|
|
BPMC
77
DELISTED
Blueprint Medicines
BPMC
| $92.1M | 0.3% |
976,359
+145,260
| +17% | +$12M |
|
78
MSCI
MSCI
$40B
| $91.8M | 0.3% |
384,293
+14,425
| +4% | +$3.23M |
|
|
ETFC
79
DELISTED
E*Trade Financial Corporation
ETFC
| $91.2M | 0.3% |
2,044,041
+1,149,971
| +129% | +$54.9M |
|
|
IPG
80
DELISTED
Interpublic Group of Companies
IPG
| $90.9M | 0.3% |
4,022,827
-519,792
| -11% | -$11.5M |
|
81
CME Group
CME
$92.2B
| $90.5M | 0.29% |
466,100
-27,000
| -5% | -$4.98M |
|
82
Zoetis
ZTS
$31.6B
| $90.3M | 0.29% |
795,302
+384,212
| +93% | +$40.2M |
|
83
Chegg
CHGG
$108M
| $90.2M | 0.29% |
2,338,564
-11,979
| -0.5% | -$451K |
|
84
Okta
OKTA
$24.1B
| $90.2M | 0.29% |
730,204
-275,385
| -27% | -$29.9M |
|
85
Broadcom
AVGO
$1.82T
| $90M | 0.29% |
3,125,000
-298,000
| -9% | -$8.68M |
|
|
86
Universal Health Services
UHS
$9.43B
| $89.6M | 0.29% |
+687,024
| New | +$86.5M |
|
87
Paycom
PAYC
$6.78B
| $89.4M | 0.29% |
394,502
-62,224
| -14% | -$12.8M |
|
88
MarketAxess Holdings
MKTX
$4.15B
| $89.3M | 0.29% |
277,938
+85,586
| +44% | +$24.7M |
|
89
RingCentral
RNG
$4.05B
| $89.3M | 0.29% |
776,728
-107,853
| -12% | -$12.4M |
|
90
Veeva Systems
VEEV
$30.3B
| $88.7M | 0.29% |
547,288
+488,288
| +828% | +$71.2M |
|
91
UDR
UDR
$12.9B
| $88.7M | 0.29% |
1,975,420
-25,862
| -1% | -$1.16M |
|
92
East-West Bancorp
EWBC
$17.9B
| $88.5M | 0.29% |
1,891,522
+77,261
| +4% | +$3.7M |
|
93
Alexandria Real Estate Equities
ARE
$8.88B
| $88.3M | 0.29% |
625,492
-17,567
| -3% | -$2.54M |
|
94
Starbucks
SBUX
$118B
| $88.2M | 0.29% |
1,052,016
+44,466
| +4% | +$3.49M |
|
|
SAGE
95
DELISTED
Sage Therapeutics
SAGE
| $87.6M | 0.28% |
478,611
-142,057
| -23% | -$24.2M |
|
96
Marathon Petroleum
MPC
$90.3B
| $87.2M | 0.28% |
1,560,551
-657,473
| -30% | -$36M |
|
|
97
American International
AIG
$41.9B
| $87.1M | 0.28% |
+1,634,722
| New | +$81.4M |
|
98
Sysco
SYY
$39.7B
| $86.8M | 0.28% |
1,226,903
+499,058
| +69% | +$35.5M |
|
|
99
Dow Inc
DOW
$21.6B
| $86.2M | 0.28% |
+1,747,600
| New | +$92.3M |
|
100
Guardant Health
GH
$19.5B
| $85.2M | 0.28% |
987,368
+603,938
| +158% | +$46.1M |
|
Similar funds
Lord, Abbett & Co's Q2 2019 Portfolio in Review
As of Q2 2019, Lord, Abbett & Co held 851 positions worth $30.8B, up 2.5% from $30B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Lord, Abbett & Co withdrew a net $14.8B in Q2 2019, closing 99 positions and reducing 305 holdings. Its most notable exit was DuPont de Nemours, an estimated $120M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Dow Inc worth $86.2M.
- Lord, Abbett & Co's largest Q2 2019 buy was Dow Inc: 1,747,600 shares worth $86.2M.
- Lord, Abbett & Co added most to Clorox in Q2 2019, an estimated $90.2M increase.
- Lord, Abbett & Co's biggest Q2 2019 reduction was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $13.2B.
- Lord, Abbett & Co fully exited DuPont de Nemours in Q2 2019, selling an estimated $120M.
- Lord, Abbett & Co's ten largest holdings make up 8.3% of its $30.8B portfolio in Q2 2019.
- Lord, Abbett & Co opened 152 new positions and closed 99 in Q2 2019.
- Lord, Abbett & Co's portfolio value rose 2.5% quarter-over-quarter to $30.8B.
Based on Lord, Abbett & Co's 13F filing for Q2 2019, filed 14 Aug 2019.